CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials

被引：124

作者：

Maisey, NR ^{[1
]}

Norman, AR ^{[1
]}

Hill, A ^{[1
]}

Massey, A ^{[1
]}

Oates, J ^{[1
]}

Cunningham, D ^{[1
]}

机构：

[1] Royal Marsden Hosp, Dept Med, Sutton SM2 5PT, Surrey, England

来源：

BRITISH JOURNAL OF CANCER | 2005年 / 93卷 / 07期

关键词：

pancreatic cancer; CA19-9; prognosis; chemotherapy;

D O I：

10.1038/sj.bjc.6602760

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In a multivariate analysis of 154 patients receiving chemotherapy, baseline CA19-9 was an independent prognostic factor for overall survival (OS) (HR 1.8; 95% CI: 1.3 - 2.5, P = 0.0004). The 1-year OS was 19 and 46%, respectively, for patients with a baseline CA19-9 above or below the median value. A fall of 20% in CA19-9 level from baseline was an independent prognostic factor for OS ( HR 1.9; 95% CI: 1.1 - 3.4, P = 0.019).

引用

页码：740 / 743

页数：4

共 50 条

[31] The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice
Engle, Dannielle
Tiriac, Herve
Rivera, Keith
Pommier, Arnaud
Whalen, Sean
Oni, Tobiloba
Alagesan, Brinda
Lee, Eun
Yao, Melissa
Lucito, Matthew
Spielman, Benjamin
Yu, Kenneth
Grutzmann, Robert
Aust, Daniela
Gimotty, Phyllis
Pollard, Katherine
Hruban, Ralph
Goggins, Michael
Pilarsky, Christian
Park, Young
Pappin, Darryl
Hollingsworth, Michael A.
Tuveson, David
CANCER RESEARCH, 2019, 79 (24)
[32] Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter
Luo, Guopei
Jin, Kaizhou
Deng, Shengming
Cheng, He
Fan, Zhiyao
Gong, Yitao
Qian, Yunzhen
Huang, Qiuyi
Ni, Quanxing
Liu, Chen
Yu, Xianjun
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1875 (02):
[33] The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer
Ni, XG
Bai, XF
Mao, YL
Shao, YF
Wu, JX
Shan, Y
Wang, CF
Wang, J
Tian, YT
Liu, Q
Xu, DK
Zhao, P
EJSO, 2005, 31 (02): : 164 - 169
[34] ASO Author Reflections: Albumin-Bilirubin Grade is an Independent Prognostic Factor Complementary to CA19-9 for Pancreatic Cancer Patients
Taisuke Imamura
Yukiyasu Okamura
Teiichi Sugiura
Yusuke Yamamoto
Takaaki Ito
Ryo Ashida
Katsuhisa Ohgi
Shimpei Ohtsuka
Katsuhiko Uesaka
Annals of Surgical Oncology, 2021, 28 : 6236 - 6237
[35] ASO Author Reflections: Albumin-Bilirubin Grade is an Independent Prognostic Factor Complementary to CA19-9 for Pancreatic Cancer Patients
Imamura, Taisuke
Okamura, Yukiyasu
Sugiura, Teiichi
Yamamoto, Yusuke
Ito, Takaaki
Ashida, Ryo
Ohgi, Katsuhisa
Ohtsuka, Shimpei
Uesaka, Katsuhiko
ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (11) : 6236 - 6237
[36] Combined pretreatment serum CA19-9 and neutrophil-to-lymphocyte ratio as a potential prognostic factor in metastatic pancreatic cancer patients
Song, Jian-Yuan
Chen, Ming-Qiu
Guo, Jing-Hua
Lian, Shi-Feng
Xu, Ben-Hua
MEDICINE, 2018, 97 (04)
[37] Serum level of TSGF,CA242 and CA19-9 in pancreatic cancer
Jing-Ting Jiang Chang-Ping Wu Hai-Feng Deng Ming-Yang Lu Jun Wu Hong-Yu Zhang Wen-Hui Sun Mei Ji Department of Tumor Biological Treatment
World Journal of Gastroenterology, 2004, (11) : 1675 - 1677
[38] CA125 is Superior to CA19-9 in Predicting the Resectability of Pancreatic Cancer
Guopei Luo
Zhiwen Xiao
Jiang Long
Zuqiang Liu
Liang Liu
Chen Liu
Jin Xu
Quanxing Ni
Xianjun Yu
Journal of Gastrointestinal Surgery, 2013, 17 : 2092 - 2098
[39] CA125 is Superior to CA19-9 in Predicting the Resectability of Pancreatic Cancer
Luo, Guopei
Xiao, Zhiwen
Long, Jiang
Liu, Zuqiang
Liu, Liang
Liu, Chen
Xu, Jin
Ni, Quanxing
Yu, Xianjun
JOURNAL OF GASTROINTESTINAL SURGERY, 2013, 17 (12) : 2092 - 2098
[40] Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer
Jiang, Jing-Ting
Wu, Chang-Ping
Deng, Hai-Feng
Lu, Ming-Yang
Wu, Jun
Zhang, Hong-Yu
Sun, Wen-Hui
Ji, Mei
WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (11) : 1675 - 1677

← 1 2 3 4 5 →